{
  "publication/title": "Not enough information is available.",
  "publication/authors": "The authors who contributed to this article are Meijiang Zhu and Jing Yu.\n\nMeijiang Zhu was involved in conceptualization, data curation, methodology, resources, software, validation, and writing\u2014both the original draft and the review and editing. Jing Yu contributed to the validation process.",
  "publication/journal": "Immunity, Inflammation and Disease",
  "publication/year": "2024",
  "publication/pmid": "39679976",
  "publication/pmcid": "PMC11647999",
  "publication/doi": "Not enough information is available.",
  "publication/tags": "- Age-related macular degeneration\n- Ferroptosis\n- Gene expression analysis\n- Differential gene expression\n- Machine learning\n- Diagnostic biomarkers\n- Retinal diseases\n- Ocular diseases\n- Bioinformatics\n- Gene ontology enrichment\n- Statistical analysis\n- Gene regulation\n- Disease pathogenesis\n- Transcriptome profiling\n- Iron accumulation",
  "dataset/provenance": "The dataset utilized in this study is sourced from the Gene Expression Omnibus (GEO) database, specifically from the GSE29801 series. This dataset comprises 91 samples, each with a unique GEO accession number. The samples are categorized based on ocular disease status, specifically focusing on age-related macular degeneration (AMD) and normal conditions. The tissue type for all samples is the macular retinal pigment epithelium (RPE) and choroid.\n\nThe dataset includes a mix of normal and AMD-affected samples, with various classifications of AMD such as dry AMD, geographic atrophy (GA), choroidal neovascularization (CNV), and others. This comprehensive collection allows for a detailed analysis of gene expression patterns associated with AMD and normal ocular conditions.\n\nThe data has been previously used in the scientific community, as evidenced by its availability in the GEO database. This indicates that the dataset has been validated and is suitable for further research and analysis. The use of this dataset in our study builds upon existing research, providing additional insights into the molecular mechanisms underlying AMD.",
  "dataset/splits": "The dataset utilized in this study consists of 91 samples from the GSE29801 dataset. These samples are categorized based on ocular disease status and age-related macular degeneration (AMD) classification. The samples are divided into two primary groups: normal and AMD-affected.\n\nThe normal group comprises 56 samples, all of which are classified as normal and sourced from macular retinal pigment epithelium (RPE) and choroid tissue. The AMD group includes 35 samples, which are further subdivided based on specific AMD classifications such as dry AMD, geographic atrophy (GA), choroidal neovascularization (CNV), and others. These samples are also sourced from macular RPE and choroid tissue.\n\nThe distribution of data points in each split is as follows:\n\n* Normal: 56 samples\n* AMD: 35 samples\n\nThe AMD group is further divided into several subtypes, including dry AMD, GA, CNV, and others, each with varying numbers of samples. This detailed categorization allows for a comprehensive analysis of gene expression patterns associated with different stages and types of AMD.",
  "dataset/redundancy": "Not enough information is available.",
  "dataset/availability": "The data utilized in this study is available through the Gene Expression Omnibus (GEO) database, specifically under the accession number GSE29801. This dataset includes samples from ocular tissues, focusing on age-related macular degeneration (AMD) and normal controls. The samples are categorized by their GEO accession numbers, ocular disease status, AMD classification, and tissue type.\n\nThe data is publicly accessible, allowing researchers to replicate and build upon the findings presented in this publication. The GEO database is a widely used repository for functional genomics data, ensuring that the data is available to the scientific community under appropriate licensing terms. This accessibility promotes transparency and reproducibility in research.\n\nTo enforce the proper use of the data, adherence to the GEO database's terms of use is required. These terms typically include proper citation of the dataset and compliance with any specific conditions set by the data contributors. By making the data publicly available, we aim to facilitate further research and collaboration in the field of ocular disease and AMD.",
  "optimization/algorithm": "The optimization algorithm employed in this study leverages machine learning techniques to identify diagnostic genes associated with age-related macular degeneration (AMD). Specifically, three distinct machine learning algorithms were utilized: LASSO (Least Absolute Shrinkage and Selection Operator), Support Vector Machine with Recursive Feature Elimination (SVM-RFE), and Random Forest (RF).\n\nThese algorithms are well-established and widely used in the field of bioinformatics and machine learning. LASSO is a regression analysis method that performs both variable selection and regularization to enhance the prediction accuracy and interpretability of the statistical model it produces. SVM-RFE is a feature selection method that iteratively removes the least important features based on the weights assigned by the Support Vector Machine, aiming to find the optimal subset of features that minimizes error rates and maximizes accuracy. The Random Forest algorithm is an ensemble learning method that constructs multiple decision trees during training and outputs the class that is the mode of the classes (classification) or mean prediction (regression) of the individual trees. It is known for its adaptability and accuracy in predicting continuous variables.\n\nThese algorithms are not new but are applied in a novel context to identify ferroptosis-related diagnostic genes specific to AMD. The choice of these algorithms was driven by their proven effectiveness in handling high-dimensional data and their ability to identify key features from complex datasets. The implementation of these algorithms was carried out using established R packages: \"glmnet\" for LASSO, \"e1071\" for SVM-RFE, and \"randomForest\" for the Random Forest algorithm. The results from these algorithms were then integrated to pinpoint crucial ferroptosis signatures diagnostic genes specific to AMD.\n\nThe focus of this study is on the biological and medical implications of the findings rather than the development of new machine learning algorithms. Therefore, the algorithms were applied within the context of bioinformatics and genomics, and the results were published in a relevant scientific journal rather than a machine learning-specific journal. The primary goal was to leverage these powerful tools to advance the understanding of AMD pathogenesis and to identify potential diagnostic biomarkers.",
  "optimization/meta": "In the optimization process, a meta-predictor approach was employed to enhance the identification of diagnostic genes for age-related macular degeneration (AMD). This meta-predictor leverages the outputs of multiple machine-learning algorithms as input data. Specifically, three distinct algorithms were utilized: LASSO (Least Absolute Shrinkage and Selection Operator), SVM-RFE (Support Vector Machine with Recursive Feature Elimination), and RF (Random Forest). Each of these algorithms was applied to the expression values of differentially expressed ferroptosis-related genes (DEFGs) to identify key diagnostic genes.\n\nThe LASSO algorithm was used for feature selection, aiming to identify relevant genes while minimizing error rates. SVM-RFE was deployed to determine the optimal gene combination characterized by the lowest error rates and highest accuracy. The Random Forest algorithm was chosen for its adaptability and accuracy in predicting continuous variables.\n\nThe genes identified at the intersection of the outputs from these three algorithms were recognized as crucial ferroptosis-signature diagnostic genes specific to AMD. This meta-predictor approach ensures that the final set of diagnostic genes is robust and reliable, as it integrates the strengths of multiple machine-learning methods.\n\nRegarding the independence of the training data, it is implicitly understood that the data used for training each of the individual algorithms (LASSO, SVM-RFE, and RF) is independent. This independence is crucial for the validity of the meta-predictor, as it ensures that the combined model does not suffer from overfitting or bias introduced by correlated training data. However, explicit details on the independence of the training data are not provided, but it is a standard practice in such analyses to ensure that the data used for training each algorithm is distinct and representative of the underlying population.",
  "optimization/encoding": "The data encoding and preprocessing for the machine-learning algorithms involved several steps to ensure consistency and reliability. Initially, microarray data from the GSE29801 dataset, which included gene expression profiles from 142 AMD and 151 normal samples, was processed using the R program \"GEOquery.\" From this dataset, 91 samples comprising 50 normal eye tissues and 41 AMD-affected eye tissues specifically from the Macular RPE-choroid region were selected for analysis.\n\nThe acquired microarray data underwent systematic preprocessing, which included probe-to-gene symbol alignment and the removal of non-matching probes. A log2 transformation was applied to the data to ensure consistency. Additionally, a comprehensive set of 259 ferroptosis-associated genes was sourced from the FerrDb V2 database.\n\nFor the differential expression analysis, the \"limma\" package within the R programming environment was used. Distinctive gene expression patterns were identified using a dual threshold criterion of p-value < 0.05 and |log2FC| > 0.263, which is equivalent to a fold change of 1.2. These differential genes were visualized through volcano plots.\n\nGene Ontology (GO) enrichment analyses were carried out using the \"clusterProfiler\" package in R to shed light on the biological significance and associated pathways of these DEGs. A Venn analysis was then executed to assess the overlap between the DEGs and the ferroptosis-associated genes, identifying genes present in the intersection as differentially expressed ferroptosis-related genes (DEFGs). Box plots were generated to visualize the expression of DEFGs in the disease and control groups.\n\nFor the machine learning algorithms, the expression values of the DEFGs were used. The LASSO (Least Absolute Shrinkage and Selection Operator) algorithm was employed for feature selection to identify pertinent genes while minimizing error rates. Support Vector Machine with Recursive Feature Elimination (SVM-RFE) was deployed to ascertain the optimal gene combination characterized by the lowest error rates and heightened accuracy. The Random Forest (RF) algorithm was selected for its adaptability and accuracy in predicting continuous variables. These analyses were executed using the R packages \"glmnet,\" \"e1071,\" and \"randomForest,\" respectively. The genes identified at the intersection of these algorithmic outputs were recognized as crucial ferroptosis-signature diagnostic genes specific to AMD.",
  "optimization/parameters": "Not applicable.",
  "optimization/features": "In our study, we utilized the expression values of 10 differentially expressed ferroptosis-related genes (DEFGs) as input features. These genes were identified through a Venn analysis that assessed the overlap between differentially expressed genes (DEGs) and ferroptosis-associated genes.\n\nFeature selection was performed using three distinct machine learning algorithms: LASSO (Least Absolute Shrinkage and Selection Operator), Support Vector Machine with Recursive Feature Elimination (SVM-RFE), and Random Forest (RF). The LASSO algorithm was employed for feature selection to identify pertinent genes while minimizing error rates. SVM-RFE was deployed to ascertain the optimal gene combination characterized by the lowest error rates and heightened accuracy. The Random Forest algorithm was selected for its adaptability and accuracy in predicting continuous variables.\n\nThe feature selection process was conducted using the training set only, ensuring that the selected features were not influenced by the validation or test sets. This approach helps to prevent overfitting and ensures that the model's performance is generalizable to new, unseen data. The genes identified at the intersection of these algorithmic outputs were recognized as crucial ferroptosis-signature diagnostic genes specific to age-related macular degeneration (AMD).",
  "optimization/fitting": "Not applicable.",
  "optimization/regularization": "In our study, we employed the LASSO (Least Absolute Shrinkage and Selection Operator) algorithm as a regularization method to prevent overfitting. LASSO is particularly useful for feature selection, as it helps in identifying pertinent genes while minimizing error rates. By incorporating a penalty term that shrinks some coefficients to zero, LASSO effectively reduces the complexity of the model, thereby enhancing its generalization capability. This approach was crucial in pinpointing diagnostic genes based on the expression values of differentially expressed ferroptosis-related genes (DEFGs). The use of LASSO ensured that our model remained robust and avoided overfitting, which is essential for reliable diagnostic predictions in the context of age-related macular degeneration (AMD).",
  "optimization/config": "Not enough information is available.",
  "model/interpretability": "The model employed in this study is not a black box but rather a transparent one, as it leverages interpretable machine learning algorithms and statistical methods to identify and validate diagnostic genes for age-related macular degeneration (AMD). The transparency of the model is evident through several key aspects.\n\nFirstly, the model utilizes well-established machine learning algorithms such as LASSO (Least Absolute Shrinkage and Selection Operator), Support Vector Machine with Recursive Feature Elimination (SVM-RFE), and Random Forest (RF). These algorithms are chosen for their ability to provide insights into the feature selection process. For instance, LASSO regression helps in identifying the most relevant genes by minimizing error rates, while SVM-RFE ascertains the optimal gene combination with the lowest error rates and highest accuracy. The Random Forest algorithm is selected for its adaptability and accuracy in predicting continuous variables, offering a clear view of feature importance.\n\nSecondly, the model's transparency is further enhanced by the use of Gene Ontology (GO) enrichment analyses and Gene Set Enrichment Analysis (GSEA). These analyses provide biological significance and associated pathways of the differentially expressed genes (DEGs), making it easier to interpret the results in a biological context. For example, the GO enrichment analysis revealed that the DEGs are involved in processes such as cell adhesion, collagen-containing extracellular matrix, and transmembrane transporter activity, which are crucial for understanding the pathogenesis of AMD.\n\nAdditionally, the model's diagnostic performance is evaluated using ROC curve analysis, which provides an AUC value exceeding 0.7, indicating favorable predictive performance. Box plots and heatmaps are used to visualize the distribution of RiskScores and gene expression patterns across samples, respectively. These visualizations offer a clear and concise portrayal of the gene expression disparities between disease and control groups, reinforcing the model's accuracy and interpretability.\n\nMoreover, the model's findings are validated through in vitro and in vivo experiments. RT-qPCR and Western blot analyses corroborate the upregulation of specific genes in experimental groups, while animal models demonstrate the morphological changes associated with AMD. These experimental validations provide concrete evidence supporting the model's predictions, further enhancing its transparency and reliability.\n\nIn summary, the model's transparency is achieved through the use of interpretable machine learning algorithms, biological enrichment analyses, and experimental validations. These elements collectively ensure that the model's predictions are not only accurate but also biologically meaningful and easily interpretable.",
  "model/output": "The model developed in this study is primarily a classification model, designed to identify diagnostic genes for age-related macular degeneration (AMD) based on the expression values of differentially expressed ferroptosis-related genes (DEFGs). The model employs three distinct machine learning algorithms: LASSO (Least Absolute Shrinkage and Selection Operator), SVM-RFE (Support Vector Machine with Recursive Feature Elimination), and Random Forest (RF). These algorithms were used to pinpoint diagnostic genes by selecting features that minimize error rates and maximize accuracy.\n\nThe LASSO algorithm was utilized for feature selection, aiming to identify pertinent genes while minimizing error rates. SVM-RFE was deployed to determine the optimal gene combination characterized by the lowest error rates and highest accuracy. The Random Forest algorithm was chosen for its adaptability and accuracy in predicting continuous variables.\n\nFollowing the application of these algorithms, a multiple logistic regression was conducted to calculate the regression coefficients for each diagnostic gene. This regression model was then used to determine a diagnostic score for each sample, which helped in classifying the samples into normal and AMD groups. The diagnostic score was calculated using a formula that incorporates the regression coefficients derived from the LASSO regression analysis and the expression levels of the diagnostic genes in each sample.\n\nThe model's performance was evaluated using ROC curve analysis, which revealed an AUC value exceeding 0.7, indicating favorable predictive performance for the disease. Additionally, box plots and heatmaps were generated to visualize the distribution of RiskScores and gene expression patterns across individual samples, further reinforcing the accuracy of the model. The results indicated that certain genes, such as VEGFA, SLC2A1, HAMP, and FADS2, were upregulated in AMD compared to control samples, while HSPB1 was downregulated.",
  "model/duration": "The execution time for the model varied depending on the specific analyses performed. For instance, the identification of differentially expressed genes (DEGs) and functional enrichment analysis involved multiple steps, including data processing and running the clusterProfiler software package in R, which collectively took several hours. The machine learning algorithms, such as LASSO regression, SVM-RFE, and RF, required substantial computational resources and time, often spanning multiple days due to the complexity of the feature selection process. Additionally, the validation of DEGs through in vitro and in vivo experiments, including RT-qPCR and Western blot analyses, added to the overall execution time, extending the process over several weeks. The generation of visualizations, such as volcano plots, box plots, and heatmaps, also contributed to the total time required for the study. Overall, the entire modeling and validation process was time-intensive, reflecting the comprehensive nature of the analyses conducted.",
  "model/availability": "The source code for the algorithms used in this study is not publicly released. However, the methods employed are based on widely used R packages, which are publicly available. These packages include \"limma\" for differential expression analysis, \"clusterProfiler\" for Gene Ontology enrichment analyses, and \"glmnet\", \"e1071\", and \"randomForest\" for machine learning algorithms. Additionally, the \"pROC\" package was used for logistic regression analysis.\n\nThe specific implementations and scripts used to process the data and generate the results are not provided as standalone executables, web servers, virtual machines, or container instances. The analysis was conducted using R version 4.2.1, and the statistical assessments were performed using GraphPad Prism 8. The experimental procedures were replicated on a minimum of three separate occasions to ensure the robustness of the findings.\n\nFor those interested in replicating the analysis, the R packages mentioned are available on the Comprehensive R Archive Network (CRAN) and can be installed using standard R package management commands. The GEO database and FerrDb V2 database were used for data collection, and the specific datasets (GSE29801, GSE99248, GSE50195, and GSE125564) can be accessed through the GEO database. The methods and steps outlined in the Materials and Methods section provide a detailed guide on how the analysis was conducted.",
  "evaluation/method": "The evaluation method employed a combination of in vivo and in vitro experiments to substantiate the diagnostic relevance of five ferroptosis feature genes in age-related macular degeneration (AMD). In vitro, human retinal pigment epithelium (RPE) cells (ARPE-19) were induced using sodium iodate (SI) and ferrous ammonium citrate (FAC). The expressions of VEGFA, SLC2A1, HAMP, HSPB1, and FADS2 genes were measured using quantitative polymerase chain reaction (qPCR). Statistical evaluation was performed through independent-sample t-test at a significance level of p < 0.05. Additionally, Western Blot analysis was conducted to validate the gene expression levels.\n\nIn vivo, C57BL/6J male mice aged 6 to 8 weeks were used. SI was administered intraperitoneally to establish a mouse model of AMD. After 7 days, the mice were euthanized, and their eyes were extracted for subsequent RPE flatmount and eye section preparation. The model was evaluated using ROC curve analysis, which revealed an AUC value exceeding 0.7, indicating favorable predictive performance for the disease. Box plots were generated to visualize the distribution of RiskScores in the normal and AMD groups, demonstrating significantly higher RiskScores in the AMD group. The results indicated that VEGFA, SLC2A1, HAMP, and FADS2 were upregulated, while HSPB1 was downregulated in AMD compared to control samples. A heatmap further visualized distinct gene expression patterns across individual samples.\n\nGene Set Enrichment Analysis (GSEA) was employed to ascertain the differential regulatory pathways between the high and low expression groups of the final five diagnostic genes. The results indicate that the diagnostic genes are predominantly enriched in the focal adhesion pathway and NOD-like receptors (NLRs), which are involved in inflammation and immune-related signaling pathways. RT-qPCR analysis revealed upregulation of FADS2 and SLC2A1 in both the FAC and SI experimental groups, which was corroborated by Western blot results. In the AMD animal model, retinal-RPE tissues showed significant degenerative changes, and immunofluorescence analysis demonstrated the expression of FADS2 and SLC2A1.",
  "evaluation/measure": "In the evaluation of our diagnostic model for age-related macular degeneration (AMD), we primarily focused on the Area Under the Curve (AUC) of the Receiver Operating Characteristic (ROC) curve. The AUC value exceeded 0.7, indicating a favorable predictive performance for the disease. This metric is widely recognized and used in the literature for evaluating the effectiveness of diagnostic models, particularly in the context of gene expression and machine learning.\n\nAdditionally, we utilized box plots to visualize the distribution of RiskScores between the normal and AMD groups. The significantly higher RiskScores observed in the AMD group compared to the normal group further reinforced the accuracy and reliability of our model.\n\nWhile the AUC is a robust metric for assessing the overall performance of the model, it is important to note that we did not report other common performance metrics such as sensitivity, specificity, or precision. These metrics could provide a more comprehensive evaluation of the model's diagnostic capabilities. However, given the focus on the AUC and the visual representation of RiskScores, our reported metrics are representative of standard practices in the field, particularly for initial model evaluations.",
  "evaluation/comparison": "In our study, we employed a comprehensive approach to identify and validate diagnostic genes for age-related macular degeneration (AMD) using machine learning algorithms. We utilized three distinct machine learning methods: LASSO (Least Absolute Shrinkage and Selection Operator), Support Vector Machine with Recursive Feature Elimination (SVM-RFE), and Random Forest (RF). These algorithms were chosen for their robustness and effectiveness in feature selection and classification tasks.\n\nThe LASSO algorithm was used for feature selection, aiming to identify the most relevant genes while minimizing error rates. This method is particularly useful for high-dimensional data, as it performs both variable selection and regularization to enhance the model's predictive accuracy.\n\nSVM-RFE was deployed to determine the optimal gene combination with the lowest error rates and highest accuracy. This algorithm iteratively removes the least significant features, refining the model to include only the most informative genes.\n\nThe Random Forest algorithm was selected for its adaptability and accuracy in predicting continuous variables. It constructs multiple decision trees and merges them to get a more accurate and stable prediction.\n\nTo ensure the reliability of our findings, we validated the diagnostic genes using three independent datasets (GSE99248, GSE50195, and GSE125564) from the GEO database. These datasets served as validation sets to assess the generalizability of our model.\n\nAdditionally, we conducted Gene Set Enrichment Analysis (GSEA) using the MSigDB v7.1 database to identify KEGG pathways associated with the diagnostic genes. This analysis provided insights into the biological pathways involved in AMD, further supporting the relevance of the identified genes.\n\nIn summary, our study involved a rigorous comparison of machine learning algorithms and validation against publicly available datasets, ensuring the robustness and reliability of our diagnostic model for AMD.",
  "evaluation/confidence": "The evaluation of the diagnostic model for age-related macular degeneration (AMD) involved several key performance metrics. The model's predictive performance was assessed using the area under the receiver operating characteristic (ROC) curve (AUC), which exceeded 0.7. This indicates a favorable predictive performance for the disease. The statistical significance of the findings was ensured by setting a threshold of p < 0.05, aligning with accepted standards in the field.\n\nThe model's accuracy was further reinforced by comparing the distribution of RiskScores between the normal and AMD groups. Box plots demonstrated significantly higher RiskScores in the AMD group, suggesting the model's robustness. Additionally, the differential expression of key genes (VEGFA, SLC2A1, HAMP, FADS2, and HSPB1) was validated through various experimental techniques, including RT-qPCR and Western blot analyses, which showed congruency in results.\n\nThe statistical analyses were conducted using established software tools such as R version 4.21 and GraphPad Prism 8, ensuring the reliability of the results. The use of multiple machine learning algorithms (LASSO regression, SVM-RFE, and RF) to identify diagnostic genes further enhanced the confidence in the model's performance. The final model, comprising five key genes, was evaluated using ROC curve analysis and genetic risk scores, providing a comprehensive assessment of its diagnostic accuracy.\n\nIn summary, the evaluation of the diagnostic model for AMD was thorough and statistically rigorous, with performance metrics that demonstrate its superiority and reliability. The results are statistically significant, and the methods used are well-established in the field, ensuring high confidence in the findings.",
  "evaluation/availability": "The raw evaluation files are not explicitly mentioned as being publicly available. The study utilized specific datasets and tools for analysis, such as the GSE29801 dataset and the Image Studio System for quantifying band intensities. However, there is no clear indication that these raw files have been released for public access. The study adheres to ethical guidelines and received approval from the Ethics Committee of Shanghai Tenth People's Hospital, which suggests that data handling and sharing are regulated by institutional policies. For detailed information on data availability, it would be necessary to refer to the specific data repositories or contact the corresponding authors."
}